DK1879654T3 - Farmaceutisk kombination af et afsvampningsmiddel og en aktiv substans, som navnlig er eugenol og carvacrol - Google Patents

Farmaceutisk kombination af et afsvampningsmiddel og en aktiv substans, som navnlig er eugenol og carvacrol

Info

Publication number
DK1879654T3
DK1879654T3 DK06744740.9T DK06744740T DK1879654T3 DK 1879654 T3 DK1879654 T3 DK 1879654T3 DK 06744740 T DK06744740 T DK 06744740T DK 1879654 T3 DK1879654 T3 DK 1879654T3
Authority
DK
Denmark
Prior art keywords
carvacrol
active substance
antifungal agent
pharmaceutical combination
eugenol
Prior art date
Application number
DK06744740.9T
Other languages
Danish (da)
English (en)
Inventor
Adnane Remmal
Original Assignee
Advanced Scient Developements
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Scient Developements filed Critical Advanced Scient Developements
Application granted granted Critical
Publication of DK1879654T3 publication Critical patent/DK1879654T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06744740.9T 2005-05-13 2006-05-15 Farmaceutisk kombination af et afsvampningsmiddel og en aktiv substans, som navnlig er eugenol og carvacrol DK1879654T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2005/001317 WO2006120496A1 (fr) 2005-05-13 2005-05-13 Combinaison pharmaceutique comprenant un agent antifongique et un actif choisi parmi le carveol, l’ eugenol, le thymol, le borneol, et le carvacrol
PCT/IB2006/001329 WO2006120565A2 (fr) 2005-05-13 2006-05-15 Combinaison pharmaceutique comprenant un agent antifongique et un actif choisi parmi le carveol, l'eugenol, le thymol, le borneol, le carvacrol, et les i0n0nes alpha- et beta-.

Publications (1)

Publication Number Publication Date
DK1879654T3 true DK1879654T3 (da) 2012-08-20

Family

ID=35427301

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06744740.9T DK1879654T3 (da) 2005-05-13 2006-05-15 Farmaceutisk kombination af et afsvampningsmiddel og en aktiv substans, som navnlig er eugenol og carvacrol

Country Status (13)

Country Link
US (1) US20080214568A1 (enExample)
EP (1) EP1879654B1 (enExample)
JP (1) JP5410747B2 (enExample)
CN (1) CN101189044B (enExample)
BR (1) BRPI0610132B8 (enExample)
CA (1) CA2607561C (enExample)
DK (1) DK1879654T3 (enExample)
EA (1) EA014068B1 (enExample)
ES (1) ES2390472T3 (enExample)
MA (1) MA29907B1 (enExample)
PT (1) PT1879654E (enExample)
TN (1) TNSN07425A1 (enExample)
WO (2) WO2006120496A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201815939T4 (tr) 2004-09-28 2018-11-21 Avivagen Inc Kilo alımının ve yemden yararlanmanın teşvik edilmesine yönelik bileşimler ve yöntemler.
WO2009052629A1 (en) 2007-10-26 2009-04-30 Chemaphor Inc. Compositions and methods for enhancing immune response
US10456369B2 (en) 2009-04-30 2019-10-29 Avivagen Inc. Methods and compositions for improving the health of animals
JP5844260B2 (ja) 2009-09-24 2016-01-13 ユニリーバー・ナームローゼ・ベンノートシヤープ オイゲノール、テルピネオールおよびチモールを含む殺菌剤
EA022986B1 (ru) 2010-12-07 2016-04-29 Юнилевер Нв Композиция для ухода за полостью рта
CN102550610B (zh) * 2010-12-07 2014-12-10 菲勒斯株式会社 含有从红松球果中提取的植物杀菌素的天然抗菌剂及包含它的水果病害防除原料
US20130310452A1 (en) * 2011-02-07 2013-11-21 Firmenich Sa Antifungal flavouring ingredients and compositions
MX2014005405A (es) 2011-11-03 2014-06-23 Unilever Nv Una composicion de limpieza personal.
JP5925605B2 (ja) * 2012-06-04 2016-05-25 花王株式会社 リパーゼ活性阻害剤、抗真菌剤、及びフケ抑制剤
EP3912620A1 (en) * 2014-10-08 2021-11-24 Pacific Northwest Research Institute Methods and compositions for increasing the potency of antifungal agents
CN104642326B (zh) * 2015-02-16 2016-02-10 河南科技学院 一种含戊苯吡菌胺和香芹酚的杀菌组合物及其用途
WO2017209588A2 (fr) 2016-06-02 2017-12-07 Advanced Scientific Developements Formulation pharmaceutique de cinéol et d'amoxicilline
US10918647B2 (en) 2016-07-26 2021-02-16 University Of Southern California Selective bromodomain inhibition of fungal Bdf1
CN113116916B (zh) * 2021-05-25 2023-07-04 河北医科大学第二医院 一种治疗妇科疾病的药物组合物及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294645A (en) * 1993-06-14 1994-03-15 Doyle E. Chastain Using menth-1-en-9-ol to kill bacteria, yeast, and fungi
CA2106032C (en) * 1993-09-13 1995-11-07 Gamini Weeratunga Methods for the manufacture of fluconazole and forms thereof, intermediates useful in the manufacture thereof, and combinations comprising fluconazole
WO1995019179A1 (en) * 1994-01-14 1995-07-20 Xoma Corporation Anti-fungal methods and materials
WO1996040192A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US6319507B1 (en) * 1997-05-02 2001-11-20 Kobo Products, Inc. Agar gel bead composition and method
US6414036B1 (en) * 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
AU2002217316A1 (en) * 2001-01-03 2002-07-30 Medpharma Plc Use of terpenes for the treatment of digestive tract infections
JP2002284702A (ja) * 2001-01-19 2002-10-03 Teika Seiyaku Kk 外用抗真菌製剤
US20030064948A1 (en) * 2001-02-08 2003-04-03 Alfred Fahr Invasomes for therapy of disorders, their preparation and use
JP2002363070A (ja) * 2001-06-06 2002-12-18 Yuutoku Yakuhin Kogyo Kk 経皮吸収貼付剤
US20040071757A1 (en) * 2001-11-20 2004-04-15 David Rolf Inhalation antiviral patch
EP1455768A1 (en) * 2001-12-07 2004-09-15 Eden Research Plc Respiratory infection prevention and treatment with terpene-containing compositions
US20030225003A1 (en) * 2002-04-18 2003-12-04 Dusan Ninkov Antimicrobial therapeutic compositions for oral and topical use
US20040151771A1 (en) * 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
US20050014730A1 (en) * 2003-04-02 2005-01-20 Carlson Robert M. Anti-fungal formulation of triterpene and essential oil

Also Published As

Publication number Publication date
ES2390472T3 (es) 2012-11-13
EA014068B1 (ru) 2010-08-30
EA200702482A1 (ru) 2008-04-28
WO2006120496A1 (fr) 2006-11-16
JP5410747B2 (ja) 2014-02-05
EP1879654A2 (fr) 2008-01-23
BRPI0610132A2 (pt) 2012-09-25
PT1879654E (pt) 2012-08-29
CN101189044A (zh) 2008-05-28
MA29907B1 (fr) 2008-11-03
CA2607561C (fr) 2014-02-04
CN101189044B (zh) 2011-12-07
BRPI0610132B1 (pt) 2020-08-11
TNSN07425A1 (fr) 2009-03-17
US20080214568A1 (en) 2008-09-04
CA2607561A1 (fr) 2006-11-16
BRPI0610132B8 (pt) 2021-05-25
WO2006120565A2 (fr) 2006-11-16
EP1879654B1 (fr) 2012-07-04
JP2008540506A (ja) 2008-11-20
WO2006120565A3 (fr) 2007-08-23

Similar Documents

Publication Publication Date Title
DK2125789T3 (da) Pyrimidinylpyrazoler som insekticide og parasiticide aktivstoffer
EP2153838A4 (en) ANTI-NOROVIRUS AGENT AND COMPOSITION THEREOF
DK1876897T3 (da) Aktivstofkombinationer
DK1948149T4 (da) Formulering, som omfatter metformin og vildagliptin
DK3311805T3 (da) Sammensætninger, der omfatter svært vandopløselige farmaceutiske midler og antimikrobielle midler
BRPI0720124A2 (pt) Composições farmacêuticas e seus métodos de uso.
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
DK1890588T3 (da) Ambulant lægemiddelindretning og fremgangsmåde til kommunikation mellem lægemiddelindretninger
DK1879654T3 (da) Farmaceutisk kombination af et afsvampningsmiddel og en aktiv substans, som navnlig er eugenol og carvacrol
BRPI0716171A2 (pt) composto, composiÇço farmacÊutica e uso de um composto.
DK2119715T3 (da) Benzimidazolderivat og dets anvendelse som AII-receptorantagonisk
DK1986679T3 (da) Fremgangsmåde til forbedring af mikropartiklers farmaceutiske egenskaber omfattende diketopiperazin og et aktivt indholdsstof
ATE484194T1 (de) Wirkstoffkombinationen
BRPI0914863A2 (pt) formulação tópica estável, e, uso da mesma
EP2186889A4 (en) CDCA1-PEPTIDE AND THIS INCLUDING PHARMACEUTICALS
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
BRPI0814891A2 (pt) Composição farmacêutica contendo composto oticamente ativo tendo atividade agonista de receptor de trombopoietina, e intermediário do mesmo.
BRPI0915552A2 (pt) derivados de ciclosporina, seu uso e sua composição farmacêutica
DK2001297T3 (da) Aktivstofkombinationer insekticide egenskaber
ATE490967T1 (de) 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
BRPI0607198A2 (pt) composição, uso da composição método de tratamento doenças, e, embalagem farmacêutica
DK1939204T6 (da) Kondenseret heterocyklisk derivat, medicinalsammensætning indeholdende samme og medicinsk anvendelse deraf
DK1883452T3 (da) Farmaceutisk sammensætning indeholdende et anti-parasitmiddel og et aktivstof valgt fra thymol, eugenol eller carvacrol
BRPI0910570A2 (pt) uso de bioconjugados, e, formulações farmacêuticas
DK1968990T3 (da) Vandopløselig benzoazepinforbindelse og farmaceutisk sammensætning deraf